Atrial natriuretic peptide (ANP) plays an important role in the regulation of blood pressure through sodium-water homoeostasis. Accordingly, several investigators have raised the question of whether the gene encoding ANP is involved in the aetiology of essential hypertension or related phenotypes such as salt sensitivity. Most of the studies have used anonymous polymorphic markers of the gene, and made inconclusive claims about the disease relevance of ANP. Therefore, in order to find sequence variations with potential functional significance and to characterize the pattern of linkage disequilibrium between polymorphisms, we screened a 3368-bp genomic fragment of ANP. Subsequently we tested the association of detected polymorphisms with plasma ANP levels and with hypertension status. Two new polymorphisms were identified, in the 5h-untranslated region and exon 1 respectively, as well as three previously reported polymorphisms in intron 2 and exon 3. When analysed in 102 healthy normotensive subjects, none of the polymorphisms appeared to significantly affect plasma ANP levels. A case-control study in a Japanese population (255 hypertensive and 225 normotensive individuals) revealed a marginally significant association (P l 0n026) between an ANP polymorphism located in the 5h-untranslated region (Ck664G) and hypertension, but no association for the other polymorphisms. Each of the uncommon variants has an allele frequency of less than 10 % in Japanese people, which may have hampered our detection of a significant association between ANP variants and hypertension status (and plasma ANP levels). The pathophysiological relevance of ANP, however, needs to be further defined in relation to hypertension-associated phenotypes, and also should be examined in different ethnic groups.
INTRODUCTION
Atrial natriuretic peptide (ANP) is a potent diuretic [1] , vasorelaxant hormone [2] , which is synthesized predominantly in the cardiac atria. In response to intravascular volume expansion and blood pressure (BP) elevation, this peptide controls sodium-water balance [3] , and also exerts inhibitory (or antagonistic) effects on the renin-angiotensin-aldosterone system [4] [5] [6] [7] and other vasoactive components, including vasopressin [8, 9] and catecholamines [10, 11] , thereby acting as an antihypertensive hormone. In addition, a study using mice with a disruption of the pro-ANP gene has shown that genetically lowered production of ANP can lead to salt-sensitive hypertension [12] . Thus a number of investigators have raised the question of whether the gene encoding ANP is involved in the aetiology of essential hypertension [13] [14] [15] [16] [17] [18] [19] or related phenotypes such as salt sensitivity [20] [21] [22] [23] . All but one study [16] have declared a lack of association by testing restriction fragment length polymorphisms (RFLPs) of the gene [24] [25] [26] [27] in casecontrol studies.
Although anonymous polymorphisms, including most RFLPs, are useful for initial detection of disease association, molecular variants that may cause functional alterations should primarily be sought ; this will increase the chance of detecting a potential association [28] . The human DNA sequence is rather diverse between individuals, and one polymorphism can be found every 500-2000 bp on average [29] . Accordingly, since several molecular variants can be expected for a given gene, a single or a few randomly sampled polymorphisms would not represent the overall variation in the gene sufficiently, and would fail to demonstrate significant effects even if one has chosen a ' true ' susceptibility gene for the study. Such problems can be decreased by characterizing the pattern and degree of linkage disequilibrium among the identified variants [30] .
In the present study, we systematically screened sequence variations in a 3368-bp region of the ANP gene, which covered a series of cis-acting regulatory elements in the 5h-untranslated region (5h-UTR) (positions k1150 to k222) [31] [32] [33] , three exons, two introns and the 3h-UTR. Subsequently we tested the association of the identified polymorphisms with plasma ANP levels in 102 normotensive healthy subjects, and also conducted a case-control study in a panel of 255 hypertensive and 225 normotensive subjects.
METHODS

Study population
This study was approved by an institutional review committee, and informed consent for participation was obtained from all subjects. The study population consisted of the following three panels. The first panel comprised 179 healthy students volunteers from Shimane Medical University, and was used for the estimation of allele frequencies of ANP polymorphisms in Japanese people. The second panel comprised 102 healthy, normotensive hospital staff at the Institute for Adult Diseases, Asahi Life Foundation, Tokyo, and was used for an association study between ANP polymorphisms and plasma ANP levels. The third panel comprised 255 hypertensive and 225 normotensive subjects selected from outpatients at the same Institute. For subjects in panels 2 and 3, two BP measurements were taken with a sphygmomanometer on separate visits and averaged to give the individual's readings. For those subjects in the first panel, only the age and sex of the participants were recorded as the individual's information.
Hypertension was defined according to the following criteria : (1) systolic BP 160 mmHg and\or diastolic BP 95 mmHg on two consecutive visits for untreated subjects ; (2) patients undergoing chronic anti-hypertensive treatment, and (3) absence of a secondary form of hypertension, as assessed by extensive work-up (serum creatinine and electrolytes, chest X-ray, ECG, urinalysis and other haematological screening tests) ; subjects with a history of diabetes mellitus and renal failure were excluded from the study. Subjects with systolic BP 140 mmHg and diastolic BP 90 mmHg were categorized as a control group for the third panel, which comprised those attending voluntary health checks or with non-cardiac symptoms. All subjects in the second panel were normotensive and were not under any chronic treatment when examined.
Measurement of plasma ANP levels
Measurement procedures have been described elsewhere [34, 35] . Briefly, peripheral blood was taken after an overnight fast. All blood samples were drawn into chilled plastic syringes, transferred to chilled disposable tubes containing aprotinin and EDTA, and placed on ice. An aliquot of plasma was immediately separated by centrifugation at 4 mC and frozen at k20 mC. Samples were thawed only once, at the time of analysis. Plasma ANP levels were measured in duplicate for each individual by a radioimmunoassay specific to human α-ANP (Shionoria ANP kit).
Identification of polymorphic sites of the ANP gene
A systematic screen was undertaken to find polymorphic sites of the ANP gene. In order to increase the chance of detecting polymorphisms with potential functional significance, overlapping PCR products spanning a 3368-bp genomic region were sequenced in individuals selected according to discrepant plasma ANP levels or hypertension status. The whole DNA sequences were compared among eight individuals (four each from the lowest and highest quartiles of plasma ANP levels in the second panel). Additionally, sequences of the 5h-UTR and coding regions were compared among eight individuals (four hypertensive and four normotensive subjects in the third panel). Wang et al. [29] have estimated that a sample size of 14 gives a 50 % chance of detecting an allele with a frequency of 5 %. Thus the sample size in our study, although relatively small, suffices in principle to identify much of the common variation.
Overlapping sets of PCR primers were designed to amplify genomic fragments spanning from position k1173 to position 2195 relative to the transcription start Genetic analysis of the atrial natriuretic peptide locus Numbering in each primer name represents the nucleotide position relative to the transcription start site. A total of nine PCR primer sets were used for sequencing. Because of the presence of poly(A) n stretches and GC-rich regions in intron 2, two primer sets (1107F/1315R and 1312F/1798R) were additionally designed to allow for efficient sequencing of the corresponding regions.
Primers
Position 5h to 3h
CCTCCCAACCACCTACCAAA site [36] , which covered part of the 5h-UTR (which is known to contain a series of cis-acting regulatory elements) [31] [32] [33] , three exons, two introns and the 3h-UTR of the gene. A list of primer sets is given in Table 1 . PCR was performed in PTC-100 (MJ Research Inc.) in a 45 µl reaction volume containing 160 nmol\l each of the two strand primers, 10 mmol\l Tris\HCl (pH 8n3), 50 mmol\l KCl, 25 µmol\l of each dNTP, 1n2 units of Ampli-Taq DNA Polymerase (Perkin Elmer) and 1n5 mmol\l MgCl # . The initial denaturation for 3 min at 95 mC was followed by 35 cycles of denaturation for 20 s at 94 mC, annealing for 30 s at 60 mC or 55 mC, and extension for 30 s at 72 mC. The annealing temperature was dependent on the primer set. PCR products were gel-purified with a QIAEX II Gel Extraction Kit (QIAGEN), and then subjected to cycle sequencing by using a Dye Terminator Cycle Sequencing Ready Reaction Kit (Perkin Elmer) on an ABI 377 DNA Sequencer (Applied Biosystems) according to the manufacturer's protocol. Possible sequence variations were detected with ABI Sequence Navigator software (Applied Biosystems). Such potential heterozygote variations were then inspected visually by comparing the fluorescence peak patterns seen among several individuals, and confirmed by sequencing of the opposite strand.
Genotyping of ANP polymorphisms
Apart from the ScaI RFLP [37] , PCR primer sets were newly designed to amplify polymorphic sites of the ANP locus (Table 2) . For the Ck664G polymorphism in the 5h-UTR, one of the PCR primers was designed such that a deliberate base change was introduced, which resulted in the creation of a novel recognition site for the restriction endonuclease RsaI for the k664G allelic PCR, but not for the k664C allelic PCR, as described elsewhere [38] . The G191A polymorphism in exon 1 was genotyped by using the mutagenically separated PCR technique [39] . PCR was performed in a 15 µl reaction volume containing 0n4 unit of Ampli-Taq DNA Polymerase and conditions were the same as those described above except that 200 nmol\l FP191 and 160 nmol\l each of primers RP191G and RP191A (see Table 2 ) were mixed in a single reaction for mutagenically separated PCR. Alleles of the five ANP polymorphisms in Table 2 were determined as follows. PCR products of the G191A polymorphism in exon 1 and the deletion\insertion (D\I) polymorphism in intron 2 were separated by electrophoresis on standard denaturing polyacrylamide gels and transferred to nylon membranes (Pall). The membranes were hybridized with a $#P-labelled primer and subjected to autoradiography [40] . PCR products of the other three polymorphisms were resolved in a 4 % (w\v) agarose gel (3 % SeaKem and 1 % NuSieve agarose ; FMC Bioproducts) after enzyme digestion by appropriate restriction endonucleases, and then visualized by ethidium bromide staining.
Statistical analysis
The χ# test statistic was calculated between the genotype distribution (or allele frequencies) and plasma ANP levels (the second panel) or hypertension status (the third panel). Confounding influences of body mass index (BMI) were assessed in a multiple logistic regression model [41] . Because three polymorphisms were tested in our association study, the nominal significance level was reduced to P l 0n05\3, i.e. 0n017, using the Bonferroni correction. Given potential relationships between the alleles of a single gene transmitted on the same chromosome, statistical tests cannot be entirely independent, and the above criterion would give conservative P values. Approximate 95 % confidence intervals (CI) of the odds ratio were given by Woolf's method [42] . The extent of linkage disequilibrium between the ANP polymorphisms was expressed as Dh l D\D max , where D indicates the population linkage disequilibrium parameter and D max indicates the maximal possible value of D, as described by Thompson et al. [43] ; haplotype frequenceis were estimated from the genotyping data on the first panel by Hill's method [44] . Statistical significance was also calculated on the basis of the standardized disequilibrium whose square (under the null hypothesis Numbering in each primer name represents the nucleotide position relative to the transcription start site. F and R denote forward and reverse respectively. RP191G and RP191A are allele-specific primers for mutagenically separated PCR ; FP191 is a non-selective complementary strand primer. Deliberately introduced base changes are underlined (see the text). The primer set for the Sca I RFLP is same as previously reported [37] .
Polymorphism
Primer 
RESULTS
A total DNA sequence of 3368 bp was screened for polymorphisms in the ANP gene. Two sequence variations were newly identified : Ck664G in the 5h-UTR and G191A in exon 1. The latter resulted in the substitution of Met for Val at amino acid residue 7 of the preprohormone of ANP [36, 45] . We also detected three polymorphisms previously reported in intron 2 (HpaII RFLP and D\I polymorphism) and exon 3 (ScaI RFLP) [26, 27, 46] , whereas we did not find four other previously reported polymorphisms in the present study : a sequence variant in the 5h-UTR (presumably between positions k498 and k288 relative to the transcription start site) detected by PCR-single-strand conformation polymor- Table 3 Allele frequencies and pairwise linkage-disequilibrium coefficients (Dh) between ANP gene polymorphisms in Japanese subjects C1364A and T1766C polymorphisms correspond to HpaII and ScaI RFLPs respectively. Linkage-disequilibrium coefficients of 0n51, 0n97 and 1n00 are significantly different from 0 at P 0n001. The coefficient between Ck664G and T1766C was calculated from genotyping data from all panels of subjects (n l 761), due to very low frequencies of the rarer allele at both loci. Since genotyping data for T1766C and D/I were 100 % concordant in the first panel (n l 179), findings observed for T1766C are directly extended to D/I.
0n92/0n08 0n00 0n97 --T1766C 0n98/0n02 0n51 0n00 0n00 -D/I 0n98/0n02 (0n51) 0n00 0n00 1n00
phism (SSCP) analysis [22] , a T-to-C substitution in the 3h-UTR (position 1853) [36] and XhoI [24] and Bgl I [25] RFLPs. All five ANP polymorphisms were genotyped in the first panel, comprising 179 subjects : 130 male and 49 female students, aged 24n4p1n8 years (meanpS.D.). The genotyping data allowed us to estimate allele frequencies of individual polymorphisms and to calculate pairwise linkage disequilibrium coefficients (Table 3) . Two pairs of polymorphisms, i.e. G191A and C1364A (HpaI RFLP), and T1766C (ScaI RFLP) and the D\I polymorphism, proved to be in complete linkage disequilibrium (Dh l 1n0) with 99 % concordance of genotypes. Linkage disequilibrium was also statistically significant between Ck664G and T1766C. Therefore three Genetic analysis of the atrial natriuretic peptide locus single-nucleotide polymorphisms (G191A, T1766C and Ck664G) were used for subsequent association studies in the second and third panels of subjects. The allele frequency of the 1766C variant appeared to be very low in Japanese people (2 %) compared with a reported prevalence of 26 % in Caucasians [37] and 39-58 % in black Africans [16, 37] . This is in good agreement with previous reports that there is considerable ethnic diversity in allele frequencies of ANP variants [13, 17, 37] . Tables 4 and 5 display the clinical characteristics of individuals in the second and third panels respectively. There was no significant correlation between plasma ANP levels and any of the variables measured concomitantly, although a borderline correlation was observed with plasma aldosterone concentration. Distribution of plasma ANP levels in panel 2 was significantly skewed towards zero (skewness b " l 2n99, P 0n01 ; kurtosis b # l 29n5, P 0n01). Approximately 40 % of samples contained ANP concentrations of 1n62 pmol\l, whereas the radioimmunometric assay used reliably measured concentrations of 1n62 pmol\l [34] . We therefore did not log-transform the values for the association study. We found no significant associations between the typed polymorphisms and plasma ANP levels in the second panel of subjects (Table 6) . A casecontrol study in the third panel revealed a borderline association (P l 0n026) between k664C and hypertension, but no association for the other molecular variants (Table 6 ). On the basis of genotyping data for the three ANP polymorphisms, a parsimonious set of five haplotypes could be generated, where the k664G and 1766C variants appeared to have occurred on the common haplotype carrying 191G. Because of the low allele frequencies in our study panel, however, testing of haplotypes did not provide much additional information compared with testing of the polymorphisms individually. The lack of an observed association with G191A and T1766C was independent of BMI. Each of the three study panels was consistent with the Hardy-Weinberg equilibrium.
DISCUSSION
Our investigations involved extensive searches for molecular variants at the ANP locus, characterization of the pattern and magnitude of linkage disequilibrium among the variants, and association studies with plasma ANP levels and hypertension status. We detected a total of five polymorphisms, including two novel variants : Ck664G in the 5h-UTR and G191A in exon 1. The Ck664G polymorphism showed a borderline association with hypertension in Japanese subjects.
The two molecular variants newly identified in the Values are meanspS.D. ANOVA, analysis of variance.
Polymorphism …Ck664G G191A T1766C Japanese population may confer some functional significance. The Ck664G polymorphism is located in the 5h-flanking sequences of the gene, where a series of cisacting regulatory elements have been reported to modulate ANP gene expression in humans [31] [32] [33] . Wu et al. [33] conducted systematic deletion mutagenesis of the 5h-flanking sequences by using a chloramphenicol acetyltransferase assay, and indicated that there were two functionally important regions of the human ANP gene : between positions k1150 and k410, and between positions k410 and k222. Our search for molecular variants in 16 Japanese subjects revealed only one rare polymorphism in the corresponding regions. The G191A polymorphism in exon 1, on the other hand, alters the amino acid sequence of the preprohormone of ANP (a Met-to-Val substitution at amino acid residue 7), which is located in a hydrophobic leader segment and is removed from the mature ANP [45] . Although the relevance of the amino acid substitution located in the prosegment of ANP to mature peptide function remains to be elucidated, a possible effect is indicated by the observation that a Gly-to-Ser substitution at position 99 (in exon 2) of the prosegment of rat ANP appears to be related to differential post-translational processing in two inbred rat strains, the stroke-prone spontaneously hypertensive rat and the Wistar Kyoto rat [47] . The T1766C polymorphism (ScaI RFLP) in exon 3 has also been shown to potentially harbour functional significance [37] . This polymorphism is located within what would normally be a stop codon. A T-to-C substitution results in a change from a stop codon to Arg, and leads to an extension of the ANP by two additional arginine residues. Thus the three above-mentioned polymorphisms are considered to be plausible functional variants in the human ANP gene. Furthermore, each of two other intron 2 polymorphisms -C1364A (HpaII RFLP) and D\I -proved to be in complete linkage disequilibrium with G191A in exon 1 and T1766C (ScaI RFLP) in exon 3 respectively (Table 3) . As a consequence, findings observed for G191A and T1766C are directly extendable to C1364A and D\I respectively in Japanese subjects. One possible mechanism by which putative mutations in the ANP gene could exert their genetic effects is in determining presetting of ANP levels according to genotype, although plasma ANP levels are highly changeable within individuals to preserve sodium-water balance in the body. A few studies have reported distributions of plasma ANP levels in normal subjects (n l 10-36) compared with those in patients with essential hypertension [48] , congestive heart failure [34] or pregnancy-induced hypertension [35] . The reported mean values in normotensive subjects (2n8-6n3 pmol\l) were not much different from our results, while concentrations were increased in diseased individuals to compensate for elevated intravascular volume overload and blood pressure. To reduce such confounding effects on ANP measurements, all participants in our second panel were selected from normotensive subjects and were not undergoing any chronic treatment when examined. We tested the above hypothesis by carrying out an association study between each of the three polymorphisms (Ck664G, G191A and T1766C) and plasma ANP levels measured in this panel. None of the variants were significantly associated with plasma ANP levels in our study sample. Nevertheless, this lack of association cannot be regarded as conclusive, due to the relatively small number of subjects (n l 102) and to a number of uncontrollable factors that may affect ANP concentration. It is also possible that there exist some unidentified functional mutations upstream of position k1150 of the 5h-UTR, outside the region investigated here.
Previous studies have reported a lack of association between the D\I or T1766C (ScaI RFLP) polymorphism and hypertension [16, 19] , which appears to be concordant with our results for T1766C. On the other hand, we did not find a significant association between G191A and hypertension, in disagreement with the positive results for the HpaII RFLP in black Africans [16] . Considerable caution is needed in interpreting the marginal statistical significance with the Ck664G polymorphism (P l 0n026) observed in the present study. In theory, extremely high allele frequencies of k664C in Japanese subjects (98-99 %) may tend to cause a false positive association. The odds ratio for k664C compared with k664G is estimated to be 4n23, with a wide CI (95 % CI 1n17-15n28). However, in order to verify the $ 17 % increase in hypertension risk (corresponding to the lowest value of 95 % CI) with the k664C genotype, 30 000 individuals would be required in each group of cases and controls, with 80 % power at a 5 % type I error probability in Japanese subjects. Likewise, about 1000 individuals are required to verify the 4n23 times increase in hypertension risk with a similar statistical power. Accordingly, we can only set a limited potential value on this and the other ANP variations found in Japanese subjects due to the high allele frequencies of the common variants (inversely, low allele frequencies of the rare variants). Further investigations are required into whether these findings are simply relevant to the documentation of uncommon DNA polymorphisms in a specific population, or are applicable to other ethnic groups.
While we were preparing this paper, Halushka et al. [49] demonstrated single-nucleotide polymorphisms in a series of candidate genes for BP homoeostasis. For the ANP gene, they reported a total of six polymorphisms in European Americans and in black Africans. Although two of them appeared to be specific for European Americans, two polymorphisms -G191A and T1766C -were detected across the three ethnic groups and the other two (located in intron 1 and the 3h-UTR respectively) were not detected in our Japanese population alone. Given these findings, it will be of interest to investigate whether some of the ANP polymorphisms reported to date arose after human population differentiation.
In summary, primary efforts were directed towards screening of molecular variants of the ANP gene. However, the functional significance of any identified polymorphism is as yet uncertain. It should be noted that each of the uncommon variants has allele frequencies of less than 10 % in Japanese subjects. Given the likely ethnic variation, there may be other ' candidate ' mutations left undiscovered which are too rare to be detected in Japanese people but may be relatively common in other ethnic groups. While our data do not support an association of the ANP gene with essential hypertension, it also remains possible that the gene variants may predispose a subgroup of the population to hypertension, selected by some ' intermediate ' phenotype, such as salt sensitivity. To comprehensively examine the pathophysiological involvement of the ANP gene in hypertension, a sib-pair linkage analysis needs to be performed.
